Influence of health-insurance status on non-Hodgkin lymphoma treatment in Kenya

Joint Event on 22nd Edition of International Conference on Neonatology and Perinatology & 3rd International Conference on Pediatrics and Pediatric Surgery
May 07-08, 2018 Frankfurt, Germany

H A Martijn, F Njuguna, S Martin, J Skiles, T Vik, G Olbara, S Langat, G J L Kaspers and S Mostert

VU University Medical Center, Netherlands
Moi Teaching and Referral Hospital, Kenya
Indiana University School of Medicine, USA

ScientificTracks Abstracts: J Pediatr Care

DOI: 10.21767/2471-805X-C2-008

Abstract

Background: Non-Hodgkin lymphoma (NHL) is the most common childhood malignancy in Sub-Saharan Africa. Survival rates for NHL are higher than 80% in high-income countries. This study explores treatment outcomes of children with NHL in Kenya, a Sub-Saharan low-income country, and determines the influence of health-insurance status at diagnosis on treatment outcomes. Methods: This was a retrospective medical records study. All children diagnosed with NHL from 2010 until 2012 were included. Data on treatment outcomes and health-insurance status at diagnosis were collected. Results: Of all 63 NHL patients, 35% abandoned treatment, 22% had progressive or relapsed disease, 14% died, and 29% had event-free survival. Most patients (73%) had no health-insurance at diagnosis. Treatment outcomes in children with or without health-insurance at diagnosis differed significantly (P=0.003). The most likely treatment outcome in children with health-insurance at diagnosis was event-free survival (53%), whereas in children without health-insurance at diagnosis it was abandonment of treatment (44%). The event-free survival estimate was significantly higher in children with health-insurance at diagnosis than in patients without health-insurance at diagnosis (P=0.003). Age at diagnosis, gender, distance to hospital, duration of symptoms and stage of disease did not significantly influence treatment outcomes and event-free survival estimates. Conclusion: Survival of children with NHL in Kenya is much lower compared to high-income countries. Abandonment of treatment was the most common cause of treatment failure. Health-insurance status at diagnosis significantly impacted treatment outcomes and survival. Survival of children with NHL could increase if access to health-insurance would be improved

Biography

H A Martijn has recently completed Medical School in VU University Medical Center Amsterdam, The Netherlands. He has published a number of papers regarding Pediatric Oncology. The papers were written based on his research period in Kenya where, Dr. S Mostert, Dr. F Njuguna and Doctor2Doctor, conducted prospective, retrospective and medical record based research.
Email:hugo_martijn@live.nl
 

paper.io

agar io

wowcappadocia.com
cappadocia-hotels.com
caruscappadocia.com
brothersballoon.com
balloon-rides.net

wormax io